Patents
Literature
Patsnap Copilot is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Patsnap Copilot

403 results about "Fluorescent particle" patented technology

Whole-field testing method for internal flow of drip emitter maze flow channel

The invention discloses a whole-field testing method for the internal flow of a drip emitter maze flow channel, which belongs to the technical field of detection. Firstly, a transparent cylindrical drip emitter flow channel model and an internal flow rate testing system of the drip emitter maze flow channel are constructed, and water flow moving action is represented by the following movement of a tracer particle and a DPIV system on the basis of tracer fluorescent particles; and by a laser beam illumination flow field, a CCD camera is used for continuously shooting pictures of the flow field, and related computation is carried out on two continuous frames of particle pictures so as to obtain the characteristic parameters of the speed flow field. The invention utilizes a microscope objective to modify a conventional CCD camera so as to successfully solve the contradiction between the shooting area and the image resolution of the internal fluid flow of the critical scale of the drip emitter flow channel and successfully realize the two-dimensional whole-field and quasi-three-dimensional local undisturbed test of the internal flow field of the drip emitter flow channel. The invention has the flowing characteristics of the maze flow channel and the characteristic of being consistent with the whole-field test result display of the existing numerical simulation and water flow movement.
Owner:CHINA AGRI UNIV

Method for Determining Effectiveness of Medicine Containing Antibody as Component

Protein recognized by an antibody used as an active ingredient of an antibody medicine such as trastuzumab or an antibody used for targeting a target site of an active ingredient is highly accurately quantitatively determined by employing a quantitative tissue staining method of biological tissues, thereby providing a method for determining therapeutic effectiveness of a medicine containing such an antibody as a component. The effectiveness of a medicine containing an antibody as a component is determined by employing a tissue staining method comprising the steps of: labeling the antibody in the medicine containing an antibody as a component with a fluorescent material and contacting the thus fluorescence-labeled antibody with a tissue sample; obtaining a fluorescence image by irradiating, with excitation light, a tissue site contacted with the antibody; obtaining an autofluorescence image in the same field of view and at the same focus as in the fluorescence image in a close region on a shorter wavelength side or a longer wavelength side of an acquisition wavelength region of fluorescence emitted by the fluorescent material; obtaining a corrected fluorescence image by performing image processing for removing fluorescence brightness of the autofluorescence image from fluorescence brightness of the fluorescence image; counting the number of cells in the tissue site contacted with the antibody; measuring average fluorescence brightness per fluorescent particle; and calculating the number of fluorescent particles per cell.
Owner:TOHOKU UNIV

Method for determining cancer onset or cancer onset risk

A highly accurate and quantitative method for determining cancer onset or cancer onset risk by a quantitative tissue staining method in biological tissues using an antibody capable of recognizing a cancer growth regulatory factor or cancer metastasis regulatory factor such as PAR1 antibody, which inhibits the cancer cell mobility and infiltration is provided. Cancer onset or cancer onset risk is determined using the tissue staining method comprising the steps of: labeling an antibody which recognizes a cancer growth regulatory factor or cancer metastasis regulatory factor with a fluorescent material, and contacting the fluorescent-labeled antibody with a tissue sample; irradiating a tissue site in contact with the antibody with excitation light to acquire a fluorescence image; acquiring an autofluorescence image in a vicinity region of a short wavelength side or long wavelength side of an acquisition region of fluorescence wavelength emitted by the fluorescent material, in the same field of vision and in the same focal point as those of the fluorescence image; acquiring a corrected fluorescence image by image processing to eliminate a fluorescent brightness of the autofluorescence image from the fluorescent brightness of the fluorescence image; counting the number of cells at the tissue site in contact with the antibody; measuring a mean fluorescent brightness of a single fluorescent particle; and calculating the number of fluorescent particles per cell.
Owner:TOHOKU UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products